Etude de la relation entre le diabète sucré et la COVID-19

Abstract

There has been widespread acceptance of diabetes as a comorbidity among those who have been infected with COVID-19 or SARS-COV-2, irrespective of the prevalence of diabetes among those who have been infected with COVID-19. Nevertheless, there are other factors that may have contributed to the existence of such comorbidities, including obesity, hypertension and cardiovascular diseases. The purpose of this study was to examine the connection between COVID-19 and diabetes. In order to accomplish that, 95 persons between the ages of 20 and 80 were provided with a questionnaire. Following the conducted consultations in home diabetic it was discovered that 32 diabetics were infected with SARS-COV-2, and 32 of these patients developed diabetes as a result of the virus' infection, as opposed to the 31 diabetic control subjects. The findings indicated a high occurrence of type 2 diabetes in post-COVID diabetic patients, integrated with pre-existing diseases including hypertension (51.51%) and hyperthyroidism with a percentage of (52%), and a female predominance (62%) in all three patient groups. The vast majority of the participants in our study are on oral diabetes medications. Yet, in defiance of the hypothesis, our population did not develop corticoid-induced diabetes. In conclusion, SARS-COV-2 infection-related diabetes is associated with a variety of path physiological variables as well as implications, where infection could be a major risk factor in the development of diabetes mellitus.